載入...
Comparison of the Novel Angiotensin II Receptor Blocker Azilsartan Medoxomil vs Valsartan by Ambulatory Blood Pressure Monitoring
J Clin Hypertens (Greenwich). 2011;13:467–472. ©2011 Wiley Periodicals, Inc. Azilsartan medoxomil (AZL‐M) is a unique angiotensin II receptor blocker (ARB) under development for the treatment of hypertension. To compare this ARB with another in the class, the authors studied the effects of AZL‐M and...
Na minha lista:
| 發表在: | J Clin Hypertens (Greenwich) |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Blackwell Publishing Ltd
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8108745/ https://ncbi.nlm.nih.gov/pubmed/21762358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1751-7176.2011.00482.x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|